Key clinical point: Age greater than 65 years, cardiovascular disease, and glucocorticoid use increased the risk of hospitalization for COVID-19 in patients with inflammatory rheumatic diseases (IRDs).
Major finding: Odds ratios for hospitalization were a respective 5.1, 2.59, and 2.27 for age, cardiovascular disease, and glucocorticoid use.
Study details: A total of 192 patients enrolled in ReCoVery, the German national COVID-19 registry.
Disclosures: Dr. Regierer has received grant support and is part of speaker’s bureaus for a variety of pharmaceutical companies. Dr. Hyrich disclosed grant income from Bristol-Myers Squibb, UCB, and Pfizer, and receiving speaker fees from AbbVie.
Regierer A et al. EULAR 2020 E-Congress, Abstract CO0004.